Menu Search Icon

Dudley Lab

The Dudley Lab, associated with the Department of Microbiology, Immunology and Cancer Biology (MIC), is focused on the tumor microenvironment and mechanisms of tumor neovascularization. We use transgenic tumor models, in vivo lineage tracing strategies, and endothelial cell cultures to explore differentiation and specialization of the tumor vasculature. We are also focused on how endothelial cells, and other cell types found within the tumor microenvironment such as fibroblasts, contribute to the growth, progression, and immune surveillance of solid tumors and their metastases.

 

DEPARTMENT OF MICROBIOLOGY, IMMUNOLOGY, AND CANCER BIOLOGY
Tumor Blood Vessel

Tumor blood vessel abnormalities

Tumor associated blood vessels have irregular diameters, they are fragile, leaky, and blood flow is abnormal; there is now good evidence that these abnormalities contribute to tumor growth, metastasis, and responses to different therapies.
Read More

Microscopic image of a tumors cell

Tumor blood vessel and tumor microenvironment heterogeneity

Endothelial cells in tumors display a spectrum of responses to TGF beta that underlies the plasticity and dysfunctional features of tumor-associated vasculature.
Read More

Green dye to show the Mechanisms of tumor neovascularization

Mechanisms of tumor neovascularization

Solid tumors have diverse mechanisms for creating new blood vessels or utilizing the pre-existing vasculature to enable their survival.
Read More

Connect with Dudley Lab

Twitter Feed

DrewDudleyLabFollow

DrewDudleyLab
DrewDudleyLabDrewDudleyLab@DrewDudleyLab·
14 Sep

The MYC oncogene — the grand orchestrator of cancer growth and immune evasion | Nature Reviews Clinical Oncology https://www.nature.com/articles/s41571-021-00549-2

Reply on Twitter 1437867595676454918Retweet on Twitter 1437867595676454918Like on Twitter 14378675956764549182Twitter 1437867595676454918
Retweet on TwitterDrewDudleyLab Retweeted
MFallahiSichaniMohammad Fallahi-Sichani@MFallahiSichani·
9 Mar

Excited to share our lab's most recent paper @NatureComms. Led by Dr. Mehwish Khaliq @UVABME, @UVACancerCenter, we identify actionable epigenetic factors that link single-cell heterogeneity in melanoma differentiation state to MAPK inhibitor sensitivity: https://www.nature.com/articles/s41467-021-21784-2

Reply on Twitter 1369377105537077251Retweet on Twitter 136937710553707725112Like on Twitter 136937710553707725160Twitter 1369377105537077251
DrewDudleyLabDrewDudleyLab@DrewDudleyLab·
30 Aug

Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression | Nature Cancer https://www.nature.com/articles/s43018-021-00232-6

Reply on Twitter 1432131759530037251Retweet on Twitter 1432131759530037251Like on Twitter 14321317595300372514Twitter 1432131759530037251
Retweet on TwitterDrewDudleyLab Retweeted
uvahealthnewsUVA Health@uvahealthnews·
27 Aug

UVA Cancer Center has been awarded a Comprehensive Cancer Center designation effective Feb. 1, 2022, by the National Cancer Institute (NCI), the largest funder of cancer research in the world. @UVACancerCenter #UVA https://newsroom.uvahealth.com/2021/08/27/uva-earns-comprehensive-cancer-center-designation/

Reply on Twitter 1431232546088566784Retweet on Twitter 143123254608856678419Like on Twitter 143123254608856678466Twitter 1431232546088566784
Load More...